PhotoniCare

PhotoniCare

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5.5M

Overview

PhotoniCare is a commercial-stage medical device company revolutionizing the diagnosis of middle ear infections (otitis media) with its handheld OtoSight Middle Ear Scope. The device utilizes a miniaturized form of Optical Coherence Tomography (OCT) to provide objective, high-resolution 3D imaging of the middle ear behind the eardrum, even in the presence of earwax. Peer-reviewed clinical data demonstrates the technology's high accuracy in detecting middle ear effusion and its potential to reduce antibiotic prescriptions by 50%. With its patented imaging platform, the company is exploring expansion into other diagnostic applications in dermatology, ophthalmology, and dentistry.

OtologyOphthalmologyDermatologyDentistry

Technology Platform

Miniaturized handheld Optical Coherence Tomography (OCT) imaging platform that uses near-infrared light to provide high-resolution, cross-sectional 3D views inside living tissue.

Funding History

3
Total raised:$5.5M
Series A$3.7M
Grant$250K
Seed$1.5M

Opportunities

The massive, global incidence of pediatric ear infections creates a strong initial market for reducing antibiotic overuse.
The handheld OCT platform offers a clear path to expand into multi-billion dollar adjacent markets in primary care ophthalmology, dermatology, and dentistry, where point-of-care, high-resolution imaging is lacking.
The shift towards value-based care and early diagnosis aligns perfectly with the company's value proposition of objective data at the first point of contact.

Risk Factors

Commercial success depends on overcoming clinician inertia and securing widespread insurance reimbursement for a new diagnostic code.
Expanding into new therapeutic areas requires significant additional capital, separate clinical validation, and navigating distinct regulatory pathways and competitive landscapes dominated by large incumbents.

Competitive Landscape

In otology, OtoSight faces competition from traditional pneumatic otoscopes and tympanometry, but is first-in-class for direct middle ear imaging. For pipeline applications, competition is intense: in ophthalmology, against large desktop OCT systems (Zeiss, Heidelberg) and emerging handheld devices; in dermatology, against dermoscopes and other imaging modalities; and in dentistry, against intraoral cameras and X-rays. PhotoniCare's differentiation is its specific miniaturization for primary care use.